Business · 05/06/2023Updated: 10/17/2026 · 1 min read
FDA Announces Final Guidance on Immunotoxic Potential of Pharmaceuticals
Summary
The Food and Drug Administration (FDA) has released a final guidance for industry on evaluating the immunotoxic potential of pharmaceuticals, building on a previously issued draft guidance from February 20, 2020.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →